Transmitter mediation of the anxiolytic action of apelin-13 in male mice

Behavioural Brain Research

Volumn 263, Issue , 2014, Pages 198-202

  Telegdy, Gyula ^a   Jászberényi, Miklós ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Anxiolytic action; Apelin 13; Tranmitter mediation

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; APELIN-13 PEPTIDE; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICUCULLINE; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; METHYSERGIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; NALOXONE; NARCOTIC ANTAGONIST; NEUROTRANSMITTER RECEPTOR; PHENOXYBENZAMINE; PROPRANOLOL; SEROTONIN ANTAGONIST; SIGNAL PEPTIDE;

ANIMAL; ANXIETY; DRUG EFFECTS; DRUG THERAPY; MALE; MAZE TEST; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANXIETY; ATROPINE; BICUCULLINE; DOPAMINE ANTAGONISTS; GABA-A RECEPTOR ANTAGONISTS; HALOPERIDOL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAZE LEARNING; METHYSERGIDE; MICE; MUSCARINIC ANTAGONISTS; NALOXONE; NARCOTIC ANTAGONISTS; PHENOXYBENZAMINE; PROPRANOLOL; RECEPTORS, NEUROTRANSMITTER; SEROTONIN ANTAGONISTS;

EID: 84894050568     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.01.009     Document Type: Article

References (28)

1. Tatemoto K., Hosoya M., Habata Y., Fujii R., Kakegawa T., Zou M.X., Kawamata Y., Fukusumi S., Hinuma S., Kitada C., Kurokawa T., Onda H., Fujino M. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998, 251:471-476.
2. Kawamata Y., Habata Y., Fukusumi S., Hosoya M., Fujii R., Hinuma S., Nishizawa N., Kitada C., Onda H., Nishimura O., Fujino M. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 2001, 1538:162-171.
3. Reaux A., De Mota N., Skultetyova I., Lenkei Z., El Messari S., Gallatz K., Corvol P., Palkovits M., Llorens-Cortes C. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 2001, 77:1085-1096.
4. O'Dowd B.F., Heiber M., Chan A., Heng H.H., Tsui L.C., Kennedy J.L., Shi X., Petronis A., George S.R., Nguyen T. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993, 136:355-360.
5. Tatemoto K., Takayama K., Zou M.X., Kumaki I., Zhang W., Kumano K., Fujimiya M. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001, 99:87-92.
6. Jászberényi M., Bujdosó E., Telegdy G. Behavioral, neuroendocrine and thermoregulatory action of apelin-13. Neuroscience 2004, 129:811-816.
7. Taheri S., Murphy K., Cohen M., Sujkovic E., Kennedy A., Dhillo W., Dakin C., Sajedi A., Ghatei M., Bloom S. The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun 2002, 291:1208-1212.
8. Lee D.K., Cheng R., Nguyen T., Fan T., Kariyawasam A.P., Liu Y., Osmond D.H., George S.R., O'Dowd B.F. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000, 74:34-41.
9. Seyedabadi M., Goodchild A.K., Pilowsky P.M. Site-specific effects of apelin-13 in the rat medulla oblongata on arterial pressure and respiration. Auton Neurosci 2002, 101:32-38.
10. Brailoiu G.C., Dun S.L., Yang J., Ohsawa M., Chang J.K., Dun N.J. Apelin-immunoreactivity in the rat hypothalamus and pituitary. Neurosci Lett 2002, 327:193-197.
11. De Mota N., Lenkei Z., Llorens-Cortes C. Cloning, pharmacological characterization and brain distribution of the rat apelin receptor. Neuroendocrinology 2000, 72:400-407.
12. O'Carroll A.M., Selby T.L., Palkovits M., Lolait S.J. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta 2000, 1492:72-80.
13. Reaux A., Gallatz K., Palkovits M., Llorens-Cortes C. Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 2002, 113:653-662.
14. Telegdy G., Adamik A., Jaszberényi M. Involvement of neurotransmitters in the action of apelin-13 on passive avoidance learning in mice. Peptides 2013, 39:171-174.
15. Pellow S., Chopin P., File S., Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 14:149-167.
16. Valle A., Hoggard N., Adams A.C., Roca P., Speakman J.R. Chronic central administration of apelin-13 over 10 day increases food intake, body weight, locomotor activity and body temperature in C57BL66 mice. J Neuroendocrinol 2008, 20:79-84.
17. Cheng B., Chen J., Bai B., Xin Q. Neuroprotection of apelin and its signaling pathway. Peptides 2012, 37:171-173.
18. Newson M.J.F., Roberts E.M., Pope G.R., Lolait S.J., O'Carroll A.M. The effects of apelin on hypothalamic-pituitary-adrenal axis neuroendocrine functions are mediated through corticotrophin-releasing factor and vasopressin-dependent mechanism. J Endocrinol 2009, 202:123-129.
19. Zeng X.J., Yu S.P., Zhang L., Wei L. Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons. Exp Cell Res 2010, 316:1773-1783.
20. O'Donnel L.A., Agrawal A., Sabnekar P., Dichter M.A., Lynch D.R., Kolson D.L. Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury. J Neurochem 2007, 102:1905-1917.
21. Biró É., Tóth G., Telegdy G. Effect of receptor blockers on brain natriuretic peptide and C-type natriuretic peptide caused anxiolytic state in rats. Neuropeptides 1996, 30:59-65.
22. Biró E., Tóth G., Telegdy G. Involvement of neurotransmitters in the anxiolytic-like action of atrial natriuretic peptide in rats. Neuropeptides 1995, 29:215-220.
23. Telegdy G., Schally A.V. Neurotransmitter-mediated action of an antagonist of growth hormone-releasing hormone on anxiolysis in mice. Behav Brain Res 2012, 233:232-236.
24. Telegdy G., Adamik A. Anxiolytic action of Neuromedin-U and neurotransmitters involved in mice. Regul Pept 2013, 186:137-140.
25. Carpéné C., Dray C., Attané C., Valet P., Portillo M.P., Churruca I., Milagro F.I., Casta-Lauell I. Expanding role for the apelin/APJ system in Physiopathology. J Physiol Biochem 2007, 63:359-373.
26. Falcao-Pires I., Ladeiras-Lopes R., Leite-Moreira A.F. The apelinergic system: a promising therapeutic target. Expert Opin Ther Targets 2010, 14:633-645.
27. Kleinz M.J., Davenport A.P. Emerging roles of apelin in biology and medicine. Pharmacol Ther 2005, 107:198-211.
28. Sorli S.C., van den Berghe L., Masri B., Knibiehler B., Audigier Y. Therapeutic potential of interfering with apelin signaling. Drug Discovery Today 2006, 11:1100-1106.